Why the study?
Does a combined measles-poliomyelitis vaccine produce adequate neutralizing antibody responses in children compared to individual antigens?
Does a combined measles-poliomyelitis vaccine produce adequate neutralizing antibody responses in children compared to individual antigens?
A combined measles-poliovirus vaccine is immunogenic and safe in children, supporting its potential use for primary sensitization.
Supports evaluation of combined measles-poliovirus vaccines in children; leaves open confirmation in larger randomized trials.
Vaccine combining inactivated, concentrated measles and poliovirus antigens was prepared and administered to children in 3 doses of 0.5 ml each, 1 month apart. The neutralizing antibody responses to both antigens were determined in a group of 133 persons. The combination vaccine produced as high a percentage and titer of seroconversions as did the individual antigens alone, appeared to be stable for prolonged periods, and caused only minimal reactions upon injection. Although positive seroconversions were less in infants under 4 months of age, combined measles and polio vaccines should be considered for augmenting diphtheria-pertussis-tetanus vaccine to confer basic primary sensitization in young children.
No takes yet. Share an insight, caveat, or question.
J. David Warren (1963) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: